Influenza News and Research

Latest Influenza News and Research

CDC announces the start of National Influenza Vaccination Week

Today the Centers for Disease Control and Prevention (CDC) announced the start of National Influenza Vaccination Week. While the week was designed to highlight the importance of flu vaccinations, it also brings to light the importance of taking additional steps to keep you and your family healthy during the peak cold and flu season of December, January and beyond.

7 Dec 2009

Phase I/II clinical trial of Multimeric-001 Universal Flu Vaccine successful

BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of the development of a Universal Influenza Vaccine, announced the success of the Phase I/II clinical trial of the Company's Multimeric-001 Universal Flu Vaccine, in trials conducted at the Sourasky Medical Center in Tel Aviv, Israel.

7 Dec 2009

Amgen announces results from three studies on the safety and efficacy of Nplate

Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).

7 Dec 2009

Findings underscore the need for additional medical student education for healthcare reform

As the population of people with chronic conditions and health care costs rise, so do opportunities for implementing health prevention strategies. Jan Carney, M.D., M.P.H., associate dean for public health at the University of Vermont (UVM) College of Medicine, believes a critical strategy for reforming the health care system lies in teaching medical students about prevention and public health.

5 Dec 2009

Tips to prevent H1N1 infection

National Handwashing Awareness Week is from Dec. 6 to 12, and a Geisinger physician advises that with the presence of the H1N1 virus this year, handwashing is more important than ever.

5 Dec 2009

Too early to declare end of H1N1 pandemic, WHO says

Though there are signs the H1N1 (swine flu) has peaked in the U.S. and Canada, a WHO flu expert said Thursday it is too early to declare the pandemic over, Canadian Press reports.

4 Dec 2009

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, was named as winner of the Emerging Life Sciences Company of the Year award, at the Eastern Technology Council’s 17th annual Enterprise Awards gala.

4 Dec 2009

New study shows seasonal flu vaccine awareness is high among Hispanics, but vaccination rates are lower

Although there is high awareness of the need for seasonal influenza vaccines, a new study of Hispanics in one California county shows low rates of actual vaccination, especially among men.

4 Dec 2009

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Ninety percent of all vaccine preventable deaths occur in those 65 and older, including residents in nursing homes, according to highlighted studies in the Pennsylvania Patient Safety Authority's 2009 December Patient Safety Advisory.

4 Dec 2009

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Adaptive vaccination strategies, based on age patterns of hospitalizations and deaths monitored in real-time during the early stages of a pandemic, outperform seasonal influenza vaccination allocation strategies, according to findings reported Dec. 3 by researchers, including two from Arizona State University, in the online journal PLoS ONE.

4 Dec 2009

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

According to the World Health Organization, the human H1N1/09 Type A influenza ("Swine Flu") has reached a pandemic level. Over 500,000 cases have been confirmed worldwide with at least 6,500 fatalities. Since there is no longer a requirement to test and report individual cases, these numbers undoubtedly understate the real situation.

4 Dec 2009

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help to lessen the final impact of the virus, suggests an epidemiological modelling study

4 Dec 2009

New medical-scientific article on A/H1N1 epidemic

A special issue of Deutsches -rzteblatt International contains the first scientific presentation of clinical experience with the novel influenza A virus (H1N1/09) in the German-speaking countries since the start of the pandemic.

4 Dec 2009

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic.

4 Dec 2009

WHO investigates Tamiflu resistance, updates antiviral recommendations for H1N1 patients with severely compromised immune systems

Following recent reports of clusters of Tamiflu resistance, the WHO on Wednesday recommended that patients with severely weakened immune systems who become infected with the H1N1 (swine flu) virus receive additional antiviral treatment as needed throughout the duration of their illness, Agence France-Presse reports. "

4 Dec 2009

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.

3 Dec 2009

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

The Roche assay for the 2009 H1N1 influenza virus detects RNA from the 2009 H1N1 Influenza A virus and provides a rapid means of identification of patients infected with this virus. In order to ensure continued specificity and sensitivity of the Roche's Influenza A/H1N1 assay, Roche performs sequence comparisons with all available 2009 H1N1 Influenza Virus sequences on a regular basis.

3 Dec 2009

Roche ships additional quantities of Tamiflu oral suspension

Roche announced today that it has begun shipping additional quantities of Tamiflu® (oseltamivir phosphate) oral suspension (liquid).

3 Dec 2009

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

The number of H1N1 (swine flu) cases in the U.S. appears to be decreasing, the CDC said Tuesday, CQ HealthBeat reports. "Flu was widespread in 32 states by the end of the week of Nov. 21, a decrease from 43 states in the prior week and 46 states earlier this fall, according to the CDC," the news service writes. "

3 Dec 2009

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.

2 Dec 2009

Influenza News and Research

Latest Influenza News and Research

CDC announces the start of National Influenza Vaccination Week

Phase I/II clinical trial of Multimeric-001 Universal Flu Vaccine successful

Amgen announces results from three studies on the safety and efficacy of Nplate

Findings underscore the need for additional medical student education for healthcare reform

Tips to prevent H1N1 infection

Too early to declare end of H1N1 pandemic, WHO says

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

New study shows seasonal flu vaccine awareness is high among Hispanics, but vaccination rates are lower

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

New medical-scientific article on A/H1N1 epidemic

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

WHO investigates Tamiflu resistance, updates antiviral recommendations for H1N1 patients with severely compromised immune systems

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

Roche ships additional quantities of Tamiflu oral suspension

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Influenza News and Research

Latest Influenza News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in